155 related articles for article (PubMed ID: 34565210)
21. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
Szabó K; Papp G; Szántó A; Tarr T; Zeher M
Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
[TBL] [Abstract][Full Text] [Related]
23. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors.
Sjöstrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
J Immunol; 2013 Oct; 191(7):3753-63. PubMed ID: 23975864
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
Gottenberg JE; Dörner T; Bootsma H; Devauchelle-Pensec V; Bowman SJ; Mariette X; Bartz H; Oortgiesen M; Shock A; Koetse W; Galateanu C; Bongardt S; Wegener WA; Goldenberg DM; Meno-Tetang G; Kosutic G; Gordon C
Arthritis Rheumatol; 2018 May; 70(5):763-773. PubMed ID: 29381843
[TBL] [Abstract][Full Text] [Related]
25. Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State.
Ruacho G; Kvarnström M; Zickert A; Oke V; Rönnelid J; Eketjäll S; Elvin K; Gunnarsson I; Svenungsson E
J Rheumatol; 2020 Jun; 47(6):865-875. PubMed ID: 31523050
[TBL] [Abstract][Full Text] [Related]
26. Detection of anti-interferon antibodies in systemic lupus erythematosus.
Suit BE; Axelrod D; Moutsopoulos HM; Decker JL; Hooks JJ
Clin Exp Rheumatol; 1983; 1(2):133-5. PubMed ID: 6442634
[TBL] [Abstract][Full Text] [Related]
27. [Increased serum C-C chemokine ligand 19 levels correlated with B cell abnormalities in systemic lupus erythematosus].
Liu HJ; Shi LJ; Hu FL; Yao HH; Li ZG; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):829-834. PubMed ID: 29045964
[TBL] [Abstract][Full Text] [Related]
28. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
[TBL] [Abstract][Full Text] [Related]
29. Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus.
Gomez-Bañuelos E; Wahadat MJ; Li J; Paz M; Antiochos B; Celia AI; Andrade V; Ferris DP; Goldman DW; Darrah E; Petri M; Andrade F
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040804
[TBL] [Abstract][Full Text] [Related]
30. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
[TBL] [Abstract][Full Text] [Related]
31. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
32. Validation of an indirect ELISA assay for assessment of autoantibodies against full-length TRIM21 and its individual domains.
Dahl MLN; Mikkelsen JH; Hvid M; Korsholm TL; Nielsen KO; Andersen CBF; Greisen S; Deleuran B
Scand J Clin Lab Invest; 2023 Sep; 83(5):309-317. PubMed ID: 37379227
[TBL] [Abstract][Full Text] [Related]
33. Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective study.
Praprotnik S; Bozic B; Kveder T; Rozman B
Clin Exp Rheumatol; 1999; 17(1):63-8. PubMed ID: 10084034
[TBL] [Abstract][Full Text] [Related]
34. Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease.
Tanaka Y; Kusuda M; Yamaguchi Y
Mod Rheumatol; 2023 Aug; 33(5):857-867. PubMed ID: 36440704
[TBL] [Abstract][Full Text] [Related]
35. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
37. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
38. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome.
Fauci AS; Moutsopoulos HM
Arthritis Rheum; 1981 Apr; 24(4):577-83. PubMed ID: 6971105
[TBL] [Abstract][Full Text] [Related]
39. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
40. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
